DVAX Latest News, Press Relases and Analysis

All

Press Releases

9 hours ago - By: Zacks Investment Research - Mentions: IOVA

Dynavax Technologies (DVAX) Surpasses Q3 Earnings Estimates

11 hours ago - By: Dynavax Technologies - Mentions: VXRT

Dynavax Reports Third Quarter 2025 Financial Results and Announces New $100 Million Share Repurchase Program

11 hours ago - By: Dynavax Technologies - Mentions: VXRT

Dynavax Enters Exclusive License Agreement for Vaxart's Novel Oral COVID-19 Vaccine Program

20 hours ago - By: Benzinga - Mentions: TECH INSE GEF SKYT ...

Earnings Scheduled For November 5, 2025

a day ago - By: Zacks Investment Research - Mentions: QGEN

Qiagen (QGEN) Q3 Earnings and Revenues Surpass Estimates

2 days ago - By: Zacks Investment Research - Mentions: NUVB

Nuvation Bio Inc. (NUVB) Reports Q3 Loss, Tops Revenue Estimates

3 months ago - By: Stocktwits - Mentions: PKW IWMW

Dynavax’s Experimental Shingles Vaccine Shows Positive Results In Study: Retail Expects Stock Rally To Continue Into Friday

3 months ago - By: Dynavax Technologies

Dynavax Reports Second Quarter 2025 Financial Results

14 days ago - By: Dynavax Technologies

Dynavax to Report Third Quarter 2025 Financial Results and Host Conference Call on November 5, 2025

15 days ago - By: Dynavax Technologies

Dynavax Presents Positive Topline Data from Part 1 of Phase 1/2 Trial for Shingles Vaccine Candidate at IDWeek 2025 and Announces Initiation of Part 2 of Trial

a month ago - By: Benzinga - Mentions: NVAX GSK MRK PFE ...

Robert F. Kennedy Jr. Faces Impeachment Push From Haley Stevens Over 'Health Care Chaos' And Rising Costs: 'Enough Is Enough'

5 months ago - By: Dynavax Technologies

Dynavax Comments on Glass Lewis Recommendation

2 months ago - By: Dynavax Technologies

Dynavax to Participate in the 2025 Wells Fargo Healthcare Conference

3 months ago - By: Dynavax Technologies

Dynavax Announces Positive Topline Phase 1/2 Results Supporting Potential Best-in-Class Shingles Vaccine Profile

3 months ago - By: The Motley Fool

Dynavax (DVAX) Q2 Revenue Jumps 29%

3 months ago - By: Zacks Investment Research - Mentions: IMTX

Dynavax Technologies (DVAX) Q2 Earnings and Revenues Beat Estimates

3 months ago - By: Zacks Investment Research - Mentions: PTGX

Protagonist Therapeutics (PTGX) Reports Q2 Loss, Lags Revenue Estimates

3 months ago - By: Dynavax Technologies

Dynavax to Report Second Quarter 2025 Financial Results and Host Conference Call on August 7, 2025

4 months ago - By: Yahoo Finance - Mentions: BCRX

Citizens JMP Reiterates a Buy Rating on Dynavax Technologies (DVAX) With a Price Target of $31

5 months ago - By: Dynavax Technologies

Dynavax Stockholders Elect All Dynavax Director Nominees at 2025 Annual Meeting

5 months ago - By: Deep Track Capital, LP

Deep Track Capital Sends Letter to Dynavax Technologies Shareholders Offering Final Perspectives on Why Change is Needed in the Boardroom

5 months ago - By: Dynavax Technologies

Dynavax Urges Stockholders to Support Its Director Nominees at June 11 Annual Meeting

5 months ago - By: Deep Track Capital, LP

Glass Lewis Recommends Shareholders Support Deep Track’s Case for Board Change at Dynavax Technologies

5 months ago - By: Dynavax Technologies

Dynavax to Present at William Blair's 45th Annual Growth Stock Conference

6 months ago - By: Deep Track Capital, LP

Deep Track Capital Comments on ISS Recommendation

6 months ago - By: Dynavax Technologies

Leading Independent Proxy Advisory Firm ISS Recommends Stockholders Vote "FOR" All Four of Dynavax's Highly Qualified Director Nominees

6 months ago - By: Deep Track Capital, LP

Deep Track Capital Issues Letter to Fellow Dynavax Technologies Shareholders Detailing Critical Issues in Advance of Annual Meeting

6 months ago - By: Dynavax Technologies

Dynavax Files Investor Presentation Highlighting Superior Strategy and Board That is Delivering Strong Financial Results and Significant Long-Term Value

6 months ago - By: Zacks Investment Research

Dynavax Technologies (DVAX) Upgraded to Buy: Here's Why

6 months ago - By: Dynavax Technologies

DYNAVAX TECHNOLOGIES CORP (DVAX) Stock News

DVAX Latest News, Press Relases and Analysis

Dynavax Technologies (DVAX) Surpasses Q3 Earnings Estimates

Dynavax Reports Third Quarter 2025 Financial Results and Announces New $100 Million Share Repurchase Program

Dynavax Enters Exclusive License Agreement for Vaxart's Novel Oral COVID-19 Vaccine Program

Earnings Scheduled For November 5, 2025

Qiagen (QGEN) Q3 Earnings and Revenues Surpass Estimates

Nuvation Bio Inc. (NUVB) Reports Q3 Loss, Tops Revenue Estimates

Dynavax’s Experimental Shingles Vaccine Shows Positive Results In Study: Retail Expects Stock Rally To Continue Into Friday

Dynavax Reports Second Quarter 2025 Financial Results

Dynavax to Report Third Quarter 2025 Financial Results and Host Conference Call on November 5, 2025

Dynavax Presents Positive Topline Data from Part 1 of Phase 1/2 Trial for Shingles Vaccine Candidate at IDWeek 2025 and Announces Initiation of Part 2 of Trial

Robert F. Kennedy Jr. Faces Impeachment Push From Haley Stevens Over 'Health Care Chaos' And Rising Costs: 'Enough Is Enough'

Dynavax Comments on Glass Lewis Recommendation

Dynavax to Participate in the 2025 Wells Fargo Healthcare Conference

Dynavax Announces Positive Topline Phase 1/2 Results Supporting Potential Best-in-Class Shingles Vaccine Profile

Dynavax (DVAX) Q2 Revenue Jumps 29%

Dynavax Technologies (DVAX) Q2 Earnings and Revenues Beat Estimates

Protagonist Therapeutics (PTGX) Reports Q2 Loss, Lags Revenue Estimates

Dynavax to Report Second Quarter 2025 Financial Results and Host Conference Call on August 7, 2025

Citizens JMP Reiterates a Buy Rating on Dynavax Technologies (DVAX) With a Price Target of $31

Dynavax Stockholders Elect All Dynavax Director Nominees at 2025 Annual Meeting

Deep Track Capital Sends Letter to Dynavax Technologies Shareholders Offering Final Perspectives on Why Change is Needed in the Boardroom

Dynavax Urges Stockholders to Support Its Director Nominees at June 11 Annual Meeting

Glass Lewis Recommends Shareholders Support Deep Track’s Case for Board Change at Dynavax Technologies

Dynavax to Present at William Blair's 45th Annual Growth Stock Conference

Deep Track Capital Comments on ISS Recommendation

Leading Independent Proxy Advisory Firm ISS Recommends Stockholders Vote "FOR" All Four of Dynavax's Highly Qualified Director Nominees

Deep Track Capital Issues Letter to Fellow Dynavax Technologies Shareholders Detailing Critical Issues in Advance of Annual Meeting

Dynavax Files Investor Presentation Highlighting Superior Strategy and Board That is Delivering Strong Financial Results and Significant Long-Term Value

Dynavax Technologies (DVAX) Upgraded to Buy: Here's Why

Dynavax Issues Statement and Mails Letter to Stockholders Emphasizing Record Financial Results and Continued Momentum